SCIE期刊BIOPHARM INTERNATIONAL 2024/2025影響因子:0.114 (BIOPHARM INT) (1542-166X). (BIOTECHNOLOGY & APPLIED MICROBIOLOGY)(生物技

hypertension

muscle-fibers

hegemony

Submitted on: 12 November 2022. Revised on: 28 December 2022. Accepted on: 12 February 2023. ___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC

強(qiáng)壯

Submitted on: 11 March 2010. Revised on: 11 May 2010. Accepted on: 04 June 2010. ___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC

hangdog

Submitted on: 19 August 2003. Revised on: 18 November 2003. Accepted on: 16 December 2003. ___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC

organism

Submitted on: 17 August 2006. Revised on: 06 December 2006. Accepted on: 10 January 2007. ___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC